10x? Try 25x... $MNMD MindMed Reports Third Qua
Post# of 102225
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
--On track to initiate the Phase 3 Voyage study of MM120 Orally Disintegrating Tablet (ODT) in Generalized Anxiety Disorder (GAD) in the fourth quarter of 2024; 12-week topline data anticipated in the first half of 2026--
https://www.businesswire.com/news/h...r-2024-...ss-Updates
--On track to initiate the Phase 3 Panorama study of MM120 ODT in GAD and the Phase 3 Emerge study of MM120 ODT in Major Depressive Disorder (MDD) in the first half of 2025--
--Cash and cash equivalents of $295.3 million as of September 30, 2024, expected to fund operations into 2027 and extend at least 12 months beyond the first Phase 3 topline data readout for MM120 ODT in GAD--
RFK Jr. Pledges To Legalize Marijuana And Psychedelics, Using Revenue To Fund Farms Where People Recovering From Drug Addiction Can Grow Organic Food
https://www.marijuanamoment.net/rfk...ng-from...anic-food/
“I would legalize psychedelic drugs—some form of legalization,” he said, adding that he doesn’t necessarily envision a commercial market where anyone could visit a shop to buy the substances, but that there should be regulated access”